Kalorama: Visualization software market is on the rise

Medical visualization software that allows multiple physicians to consult on a patient’s condition is one of the key areas of growth for virtual reality technologies in healthcare, according to a study by Kalorama Information.

The study, titled “Virtual Reality (VR) in Healthcare in the U.S.,” predicts medical visualization software revenues will rise 12 percent annually for the next five years as more  physicians access advanced visualization technology over increasingly prevalent health IT systems and internet-based applications.

The Kalorama study looked at virtual reality technologies in four application areas, one of which was medical data visualization, including multi-modality image fusion, advanced 2D/3D/4D image reconstruction, and pre-operative planning and other advanced analytical software tools.

Growth is expected in this area because because healthcare organizations have longstanding investments in radiology department IT (such as RIS) and inter-departmental PACS. These IT investments provide the basis for integration of medical visualization software, according to the New York City-based healthcare market researcher. Film and other media are being replaced by digital copies accessible to multiple consulting physicians through health IT systems and thin-client applications; advanced visualization enables image navigation and interaction, according to the report.
 
Server-based departmental and thin-client medical imaging systems have expanded the client base for advanced visualization software by offering powerful rendering and intensive virtual reality capabilities to physicians' PCs and imaging consoles. Revenue from departmental software licenses will rise as organizations take advantage of "economical enterprise-wide server and license packages with integrated advanced visualization software suites,” the report states.



Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup